《2025年AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM成人高血压预防、检测、评估和管理指南》要点解读

Interpretation on the Key Points of 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/ SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults

  • 摘要: 2025年8月,美国心脏协会、美国心脏病学会等十余家学术机构共同颁布了新版成人高血压预防、检测、评估和管理指南。新版指南整合了最新临床证据,体现了基于风险的“全面血压控制”和“全生命周期管理”的指导思想,对于高血压诊断标准、强化降压策略、继发性高血压筛查、降压药物治疗及器械治疗等均给出了更为积极的推荐。该指南的更新对于我国高血压防治措施的修订具有重要指导意义。

     

    Abstract: In August 2025, the American Heart Association, American College of Cardiology, and more than ten other academic organizations jointly released an updated guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Integrating the latest clinical evidence, the new guideline reflects a risk-based approach centered on “comprehensive blood pressure control” and “lifespan management.” It provides more proactive recommendations in areas including diagnostic criteria for hypertension, intensive blood pressure–lowering strategies, screening for secondary hypertension, and the use of antihypertensive pharmacotherapy and device-based therapies. This updated guideline holds significant implications for refining hypertension prevention and management strategies in China.

     

/

返回文章
返回